Mm. Devilliers, INFLUENCE OF COHESIVE PROPERTIES OF MICRONIZED DRUG POWDERS ON PARTICLE-SIZE ANALYSIS, Journal of pharmaceutical and biomedical analysis, 13(3), 1995, pp. 191-198
Particle size analysis results with respect to micronized, mean partic
le size below 10 mu m, furosemide, chloramphenicol palmitate and aceta
minophen particles are dealt with in this paper. Special consideration
was given to the effect of the agglomeration of particles on data gen
erated by three size measurement techniques. The physicochemical basis
for preparing sufficiently well dispersed and stable suspensions for
analysis by employing mechanical methods of pretreatment are shown. Fu
rthermore, methods to determine the state of dispersion and methods to
assess the individual particle size before size analysis are describe
d. An attempt was also made to establish the statistical confidence th
at can be assigned to a particular instrument and the confidence level
that may be placed on comparative data obtained with the different pa
rticle size analysers. Results especially showed the impact of the agg
lomeration of very small furosemide particles, mean size 3 mu m, on pa
rticle size analysis and the importance of controlling the cohesive pr
operties of this drug. To overcome the problems associated with agglom
eration more attention must be paid to the physical properties of the
drug substance. Combining particle size analysis with bulk: density, s
urface area and microscopical studies also helped to identify potentia
l problems.